WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 40.02
+0.02 (0.05%)
At close: Jan 15, 2026
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 165.43 billion as of January 15, 2026. Its market cap has increased by 137.58% in one year.
Market Cap
165.43B
Enterprise Value
161.79B
Revenue
21.98B
Ranking
n/a
PE Ratio
36.95
Stock Price
40.02
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 165.43B, an increase of 416.33%. That is a compound annual growth rate of 21.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 165.34B | 27.23% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 303.05B |
| Hansoh Pharmaceutical Group Company | 254.51B |
| JD Health International | 216.31B |
| Innovent Biologics | 154.99B |
| Sino Biopharmaceutical | 123.53B |
| Sichuan Kelun-Biotech Biopharmaceutical | 112.12B |
| CSPC Pharmaceutical Group | 111.81B |
| Akeso | 111.09B |